▶ 調査レポート

終末糖化産物(AGEs)の世界市場2021年ー2031年:種類別(非蛍光AGEs、蛍光AGEs)、用途別、エンドユーザー別

• 英文タイトル:Advanced Glycation End Products Market (Type: Non-fluorescent AGEs and Fluorescent AGEs; Application: Diabetes Complications, Cancer, Bone Diseases, Neurodegenerative Diseases, and Others; and End User: Hospitals, Specialty Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Transparency Market Researchが調査・発行した産業分析レポートです。終末糖化産物(AGEs)の世界市場2021年ー2031年:種類別(非蛍光AGEs、蛍光AGEs)、用途別、エンドユーザー別 / Advanced Glycation End Products Market (Type: Non-fluorescent AGEs and Fluorescent AGEs; Application: Diabetes Complications, Cancer, Bone Diseases, Neurodegenerative Diseases, and Others; and End User: Hospitals, Specialty Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 / MRC2111A041資料のイメージです。• レポートコード:MRC2111A041
• 出版社/出版日:Transparency Market Research / 2021年7月23日
• レポート形態:英文、PDF、187ページ
• 納品方法:Eメール
• 産業分類:バイオ
• 販売価格(消費税別)
  Single User¥770,735 (USD5,795)▷ お問い合わせ
  Site Licence¥1,169,735 (USD8,795)▷ お問い合わせ
  Enterprisewide¥1,568,735 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査資料では、終末糖化産物(AGEs)の世界市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、種類別(非蛍光AGEs、蛍光AGEs)分析、用途別分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの項目を掲載しています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・終末糖化産物(AGEs)の世界市場規模:種類別(非蛍光AGEs、蛍光AGEs)
・終末糖化産物(AGEs)の世界市場規模:用途別
・終末糖化産物(AGEs)の世界市場規模:エンドユーザー別
・終末糖化産物(AGEs)の世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Advanced Glycation End Products Market – Scope of Report

TMR’s report on the global advanced glycation end products market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global advanced glycation end products market for the period from 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global advanced glycation end products market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the advanced glycation end products market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global advanced glycation end products market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global advanced glycation end products market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global advanced glycation end products market.

The report delves into the competitive landscape of the global advanced glycation end products market. Key players operating in the global advanced glycation end products market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global advanced glycation end products market profiled in this report.

Key Questions Answered in Advanced Glycation End Products Market Report

What is the sales/revenue generated by the advanced glycation end products market across all regions during the forecast period?
What are the opportunities in the global advanced glycation end products market?
What are the major drivers, restraints, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which type segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Advanced Glycation End Products Market – Research Objectives and Research Approach

The comprehensive report on the global advanced glycation end products market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global advanced glycation end products market in terms of type, application, end user, and region. Key segments under each criterion are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global advanced glycation end products market.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Advanced Glycation End Products Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Advanced Glycation End Products Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Bioactivity of AGEs and RAGE: Flowchart
5.2. Key Trend Analysis
5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Advanced Glycation End Products Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Advanced Glycation End Products Market Value Forecast, by Type, 2017–2031
6.3.1. Non-fluorescent AGEs
6.3.1.1. Carboxymethyl-lysine (CML)
6.3.1.2. Carboxyethyl-lysine (CEL)
6.3.1.3. Pyrraline
6.3.2. Fluorescent AGEs
6.3.2.1. Pentosidine
6.3.2.2. Methylglyoxal-lysine dimer (MOLD)
6.4. Global Advanced Glycation End Products Market Attractiveness, by Type
7. Global Advanced Glycation End Products Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Advanced Glycation End Products Market Value Forecast, by Application, 2017–2031
7.3.1. Diabetic Complications
7.3.2. Cancer
7.3.3. Bone Diseases
7.3.4. Neurodegenerative Diseases
7.3.5. Others
7.4. Global Advanced Glycation End Products Market Attractiveness, by Application
8. Global Advanced Glycation End Products Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Advanced Glycation End Products Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Others
8.4. Global Advanced Glycation End Products Market Attractiveness, by End-user
9. Global Advanced Glycation End Products Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Advanced Glycation End Products Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Advanced Glycation End Products Market Attractiveness, by Country/Region
10. North America Advanced Glycation End Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Advanced Glycation End Products Market Value Forecast, by Type, 2017–2031
10.2.1. Non-fluorescent AGEs
10.2.1.1. Carboxymethyl-lysine (CML)
10.2.1.2. Carboxyethyl-lysine (CEL)
10.2.1.3. Pyrraline
10.2.2. Fluorescent AGEs
10.2.2.1. Pentosidine
10.2.2.2. Methylglyoxal-lysine dimer (MOLD)
10.3. North America Advanced Glycation End Products Market Value Forecast, by Application, 2017–2031
10.3.1. Diabetic Complications
10.3.2. Cancer
10.3.3. Bone Diseases
10.3.4. Neurodegenerative Diseases
10.3.5. Others
10.4. North America Advanced Glycation End Products Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Specialty Clinics
10.4.3. Others
10.5. North America Advanced Glycation End Products Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. North America Advanced Glycation End Products Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Advanced Glycation End Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Advanced Glycation End Products Market Value Forecast, by Type, 2017–2031
11.2.1. Non-fluorescent AGEs
11.2.1.1. Carboxymethyl-lysine (CML)
11.2.1.2. Carboxyethyl-lysine (CEL)
11.2.1.3. Pyrraline
11.2.2. Fluorescent AGEs
11.2.2.1. Pentosidine
11.2.2.2. Methylglyoxal-lysine dimer (MOLD)
11.3. Europe Advanced Glycation End Products Market Value Forecast, by Application, 2017–2031
11.3.1. Diabetic Complications
11.3.2. Cancer
11.3.3. Bone Diseases
11.3.4. Neurodegenerative Diseases
11.3.5. Others
11.4. Europe Advanced Glycation End Products Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Others
11.5. Europe Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Advanced Glycation End Products Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Advanced Glycation End Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Advanced Glycation End Products Market Value Forecast, by Type, 2017–2031
12.2.1. Non-fluorescent AGEs
12.2.1.1. Carboxymethyl-lysine (CML)
12.2.1.2. Carboxyethyl-lysine (CEL)
12.2.1.3. Pyrraline
12.2.2. Fluorescent AGEs
12.2.2.1. Pentosidine
12.2.2.2. Methylglyoxal-lysine dimer (MOLD)
12.3. Asia Pacific Advanced Glycation End Products Market Value Forecast, by Application, 2017–2031
12.3.1. Diabetic Complications
12.3.2. Cancer
12.3.3. Bone Diseases
12.3.4. Neurodegenerative Diseases
12.3.5. Others
12.4. Asia Pacific Advanced Glycation End Products Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Specialty Clinics
12.4.3. Others
12.5. Asia Pacific Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Advanced Glycation End Products Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Advanced Glycation End Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Advanced Glycation End Products Market Value Forecast, by Type, 2017–2031
13.2.1. Non-fluorescent AGEs
13.2.1.1. Carboxymethyl-lysine (CML)
13.2.1.2. Carboxyethyl-lysine (CEL)
13.2.1.3. Pyrraline
13.2.2. Fluorescent AGEs
13.2.2.1. Pentosidine
13.2.2.2. Methylglyoxal-lysine dimer (MOLD)
13.3. Latin America Advanced Glycation End Products Market Value Forecast, by Application, 2017–2031
13.3.1. Diabetic Complications
13.3.2. Cancer
13.3.3. Bone Diseases
13.3.4. Neurodegenerative Diseases
13.3.5. Others
13.4. Latin America Advanced Glycation End Products Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Specialty Clinics
13.4.3. Others
13.5. Latin America Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Advanced Glycation End Products Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Advanced Glycation End Products Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by Type, 2017–2031
14.2.1. Non-fluorescent AGEs
14.2.1.1. Carboxymethyl-lysine (CML)
14.2.1.2. Carboxyethyl-lysine (CEL)
14.2.1.3. Pyrraline
14.2.2. Fluorescent AGEs
14.2.2.1. Pentosidine
14.2.2.2. Methylglyoxal-lysine dimer (MOLD)
14.3. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by Application, 2017–2031
14.3.1. Diabetic Complications
14.3.2. Cancer
14.3.3. Bone Diseases
14.3.4. Neurodegenerative Diseases
14.3.5. Others
14.4. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Specialty Clinics
14.4.3. Others
14.5. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Advanced Glycation End Products Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Share Analysis, by Company (2020)
15.2. Company Profiles
15.2.1. AbbVie, Inc. (Allergan Plc)
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Company Financials
15.2.1.3. Growth Strategies
15.2.1.4. SWOT Analysis
15.2.2. Merck KGaA
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Company Financials
15.2.2.3. Growth Strategies
15.2.2.4. SWOT Analysis
15.2.3. Takeda Pharmaceutical Company Limited
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Company Financials
15.2.3.3. Growth Strategies
15.2.3.4. SWOT Analysis
15.2.4. Estée Lauder Companies
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Company Financials
15.2.4.3. Growth Strategies
15.2.4.4. SWOT Analysis
15.2.5. Shiseido Company, Limited
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Company Financials
15.2.5.3. Growth Strategies
15.2.5.4. SWOT Analysis
15.2.6. Beiersdorf AG
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Company Financials
15.2.6.3. Growth Strategies
15.2.6.4. SWOT Analysis
15.2.7. L’Oréal S.A.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Company Financials
15.2.7.3. Growth Strategies
15.2.7.4. SWOT Analysis
15.2.8. NuFACE
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Company Financials
15.2.8.3. Growth Strategies
15.2.8.4. SWOT Analysis
15.2.9. Rodan & Fields
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Company Financials
15.2.9.3. Growth Strategies
15.2.9.4. SWOT Analysis
15.2.10. PhotoMedex, Inc.
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Company Financials
15.2.10.3. Growth Strategies
15.2.10.4. SWOT Analysis
15.2.11. Ostium Cosmetics
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Company Financials
15.2.11.3. Growth Strategies
15.2.11.4. SWOT Analysis
15.2.12. Cell Biolabs, Inc.
15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.12.2. Company Financials
15.2.12.3. Growth Strategies
15.2.12.4. SWOT Analysis
15.2.13. Shanghai Korain Biotech Co., Ltd.
15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.13.2. Company Financials
15.2.13.3. Growth Strategies
15.2.13.4. SWOT Analysis

List of Tables

Table 01: Global Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 02: Global Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017–2031

Table 03: Global Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017–2031

Table 04: Global Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 05: Global Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: Global Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 07: North America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 08: North America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 09: North America Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017–2031

Table 10: North America Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017–2031

Table 11: North America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 12: North America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Europe Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Europe Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 15: Europe Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017–2031

Table 16: Europe Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017–2031

Table 17: Europe Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 18: Europe Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 19: Asia Pacific Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 20: Asia Pacific Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 21: Asia Pacific Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017–2031

Table 22: Asia Pacific Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017–2031

Table 23: Asia Pacific Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 24: Asia Pacific Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 25: Latin America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Latin America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 27: Latin America Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017–2031

Table 28: Latin America Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017–2031

Table 29: Latin America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 30: Latin America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 31: Middle East & Africa Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 32: Middle East & Africa Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 33: Middle East & Africa Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017–2031

Table 34: Middle East & Africa Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017–2031

Table 35: Middle East & Africa Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 36: Middle East & Africa Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031